Recombinant Mouse Podoplanin Protein，His & GST

Podoplanin, a glycoprotein primarily expressed in lymphatic endothelial cells, plays a critical role in various physiological and pathological processes, including lymphangiogenesis, tissue repair, and tumor progression. Its ability to enhance cell migration, support lymphatic vessel formation, and interact with the platelet aggregation mechanism has garnered significant research interest, particularly in cancer biology and immunology. In the context of tumor microenvironments, podoplanin is often upregulated in various malignancies, correlating with aggressive tumor behavior and poor patient prognosis. Furthermore, it serves as a potential biomarker for certain types of cancers, prompting investigations into its therapeutic targeting. The development of recombinant podoplanin proteins has emerged as a vital tool for studying its biological functions, interactions, and potential as a drug target. Researchers utilize these recombinant proteins to elucidate the signaling pathways mediated by podoplanin and to explore its roles in immune escape and tumor metastasis. The insights gained from such studies could pave the way for novel therapeutic strategies aimed at restricting tumor growth and improving clinical outcomes for patients with podoplanin-positive malignancies. As such, the ongoing research into podoplanin and its recombinant forms holds promise not only for advancing our understanding of cancer biology but also for fostering innovation in targeted therapies and diagnostics.